Organon & Co 2024 IR
The report highlights PT Organon Pharma Indonesia Tbk's performance in 2024, showcasing a 5.40% increase in net revenue to Rp2,896 billion. The company advanced its sustainability commitment through its 'Her Promise' framework, focusing on women's health, equity, and environmental care. Key environmental achievements included a reduction in electricity consumption to 9.47 million kWh and a decrease in hazardous waste generation. Additionally, the company maintained a zero-accident workplace and actively supported local communities through health and education initiatives.
Company: Organon & Co
Sector: Health Care
Country: United States
Year: 2024
Type: IR
Pages: 287
Organon & Co
Integrated Annual Report
The report highlights PT Organon Pharma Indonesia Tbk's performance in 2024, showcasing a 5.40% increase in net revenue to Rp2,896 billion. The company advanced its sustainability commitment through its 'Her Promise' framework, focusing on women's health, equity, and environmental care. Key environmental achievements included a reduction in electricity consumption to 9.47 million kWh and a decrease in hazardous waste generation. Additionally, the company maintained a zero-accident workplace and actively supported local communities through health and education initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Integrated Report
Language
English, Indonesian
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Water Consumption
Workplace Fatalities
Net Zero Target
Employees